Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
PhRMA's Narasimhan Asks Japan To Reform Pricing Policies
Phase I Waiver Plan 'Very Positive'
Nov 17 2023
•
By
Lisa Takagi
Vasant Narashimhan, Chair of the PhRMA Board of Directors at press conference in Tokyo, Japan • Source: Lisa Takagi
More from Japan
More from Focus On Asia